March 19, 2020 Bio/Pharma/CRO Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences WASHINGTON, March 19, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that the U.S. Federal Trade Commission (the “FTC”) has accepted the proposed consent order in connection with Danaher’s definitive agreement with General... Read more

March 19, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Microscopy

Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

Basel, 19 March 2020- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced  we are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of the... Read more

March 11, 2020 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention

Next-generation cytology test provides additional information for HPV-positive women who may have cervical pre-cancer More sensitive than Pap cytology testing when used as triage test for HPV-positive screening results, helping to improve the detection of cervical pre-cancer The first biomarker-based test specifically approved by the FDA to triage women with HPV-positive / Pap cytology-negative co-testing... Read more

February 10, 2020 Bio/Pharma/CRO

Roche provides topline results from investigator-led Phase II/III trial with gantenerumab in rare inherited form of Alzheimer’s disease

Primary endpoint was not met in a study sponsored by Washington University; additional analyses are ongoing to understand the totality of the data Data from study in people with or at-risk for autosomal dominant Alzheimer’s disease will be presented at the AAT-AD/PD Focus meeting in April 2020 Results do not impact Roche’s two ongoing Phase... Read more

January 27, 2020 Atomic Spectroscopy Bio/Pharma/CRO Lab Top-10 Liq. Handling & Robotics Product Launch

PerkinElmer Unveils Advanced Drug Discovery and Disease Research Solutions at SLAS2020

Workstations and high-content screening system automate workflows to help researchers generate invaluable insights WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced new workstations and a high content screening system at SLAS2020 in San Diego (booth #929). These technologies automate workflows so that disease research and drug discovery professionals can... Read more

January 24, 2020 Bio/Pharma/CRO

Roche provides an update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer

Basel, 24 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab) as an adjuvant (after surgery) monotherapy treatment did not meet its primary endpoint of disease-free survival (DFS) compared to observation in people with muscle-invasive urothelial cancer (MIUC). Safety for Tecentriq appeared consistent with... Read more

January 21, 2020 Bio/Pharma/CRO Informatics & Software Lab Top-10 Product Launch

New Thermo Scientific NanoDrop QC Software Simplifies Sample Quality Control for Industrial Users

New Thermo Scientific NanoDrop QC Software Simplifies Sample Quality Control for Industrial Users Advanced features enable chemists to measure highly-concentrated samples without dilution HILLSBORO, Ore., Jan. 21, 2020 /PRNewswire/ — Thermo Fisher Scientific today released the Thermo Scientific NanoDrop QC Software for the Thermo Scientific NanoDrop OneC Spectrophotometer. Combined with the new software, the ultraviolet-visible... Read more

November 27, 2019 Acad, Gov/Utilities Bio/Pharma/CRO Liq. Handling & Robotics

QIAGEN and DiaSorin receive FDA approval for the LIAISON QuantiFERON-TB Gold Plus Test on LIAISON platforms and begin commercial launch

Germantown, Maryland; Hilden, Germany; and Saluggia, Italy, November 27, 2019 –QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the U.S. launch of an automated workflow for QuantiFERON-TB Plus (QFT-Plus), the fourth-generation modern gold standard for latent tuberculosis (TB) detection, on DiaSorin’s LIAISON platforms. The U.S. Food and Drug Administration... Read more

November 18, 2019 Bio/Pharma/CRO Cell Analysis Tools Product Launch

Securecell Introduces Sephara, a Novel, Silicon-Based In-Situ Filtration Membrane

Monday, 18 November 2019 09:00  Hits: 2833 ShareLinkedInTwitter Sephara is changing the way automated analytical sampling as well as perfusion processes at the benchtop scale will be performed Securecell offers an early access program for the Sephara technology URDORF (Zurich), Switzerland, November 18, 2019 / B3C newswire / — Securecell today announced that it has introduced Sephara, a high performance in-situ... Read more

November 13, 2019 Bio/Pharma/CRO Lab Top-10

Thermo Fisher Scientific Opens Customer Solution Center in China to Support Pharmaceutical and Biopharmaceutical Laboratories

Thermo Fisher Scientific Opens Customer Solution Center in China to Support Pharmaceutical and Biopharmaceutical Laboratories SHANGHAI, Nov. 13, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of a Customer Solution Center in Shanghai, China. This follows the recent announcements of a Biosciences Customer Exploration Center in Shanghai and... Read more